{"name": "Galapagos",
 "permalink": "galapagos",
 "crunchbase_url": "http://www.crunchbase.com/company/galapagos",
 "homepage_url": "http://www.glpg.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "+32 15 34 29 00",
 "description": "",
 "created_at": "Fri Oct 29 04:14:57 UTC 2010",
 "updated_at": "Fri Oct 29 04:14:56 UTC 2010",
 "overview": "\u003Cp\u003EGalapagos (Euronext: GLPG; OTC: GLPYY) is a mid-size biotechnology company specialized in the discovery and development of small molecule and antibody therapies with novel modes-of-action. The Company is progressing one of the largest pipelines in biotech, with six clinical and over 50 small molecule discovery/pre-clinical programs. Through risk/reward-sharing alliances with GlaxoSmithKline, Lilly, Janssen Pharmaceutica, Merck \u0026amp; Co., Roche and Servier, Galapagos is eligible to receive up to \u00e2\u201a\u00ac3.3 billion in downstream milestones, plus royalties. The Galapagos Group has over 800 employees and operates facilities in seven countries, with global headquarters in Mechelen, Belgium.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       56],
      "assets/images/resized/0010/7810/107810v1-max-150x150.png"],
     [[240,
       91],
      "assets/images/resized/0010/7810/107810v1-max-250x250.png"],
     [[240,
       91],
      "assets/images/resized/0010/7810/107810v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Onno",
      "last_name": "van de Stolpe",
      "permalink": "onno-van-de-stolpe",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Guillaume",
      "last_name": "Jetten",
      "permalink": "guillaume-jetten",
      "image": null}},
   {"is_past": false,
    "title": "Board memeber",
    "person":
     {"first_name": "Stephen",
      "last_name": "Bunting",
      "permalink": "stephen-bunting",
      "image":
       {"available_sizes":
         [[[109,
            150],
           "assets/images/resized/0027/5899/275899v1-max-150x150.jpg"],
          [[183,
            250],
           "assets/images/resized/0027/5899/275899v1-max-250x250.jpg"],
          [[230,
            314],
           "assets/images/resized/0027/5899/275899v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac3.7M",
 "funding_rounds":
  [{"round_code": "grant",
    "source_url": "http://www.glpg.com/press/2010/40.htm",
    "source_description": "Galapagos receives \u00e2\u201a\u00ac3.7 million grant for cystic fibrosis program ",
    "raised_amount": 3700000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 28,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Industriepark Mechelen Noord ",
    "address2": "Generaal De Wittelaan L11 A3",
    "zip_code": "B-2800",
    "city": "Mechelen",
    "state_code": null,
    "country_code": "BEL",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}